Transplant Infectious Disease

Editorial
pp. 87-88(2)
Author: Rubin R.H.

High-dose acyclovir prophylaxis reduces cytomegalovirus disease in liver transplant patients
pp. 89-97(9)
Authors: Barkholt L.; Lewensohn-Fuchs I.; Ericzon B.-G.; Tydén G.; Andersson J.

Tuberculosis in renal transplant recipients
pp. 98-104(7)
Authors: Lattes R.; Radisic M.; Rial M.; Argento J.; Casadei D.

Antiviral drug resistance in human cytomegalovirus
pp. 105-114(10)
Author: Chou S.

Cytomegalovirus infection and cardiac allograft vasculopathy
pp. 115-126(12)
Authors: Koskinen P.K.; Kallio E.A.; Tikkanen J.M.; Sihvola R.K.; Häyry P.J.; Lemström K.B.

Molecular pathogenesis of human cytomegalovirus infection
pp. 127-134(8)
Author: Rasmussen L.

Reactivation of chronic Chagas’ disease following allogeneic bone marrow transplantation and successful pre-emptive therapy with benznidazole
pp. 135-137(3)
Authors: Altclas J.; Sinagra A.; Jaimovich G.; Salgueira C.; Luna C.; Requejo A.; Milovic V.; De Rissio A.; Feldman L.; Riarte A.

Infective endocarditis in renal transplant recipients
pp. 138-143(6)
Authors: Bishara J.; Robenshtok E.; Weinberger M.; Yeshurun M.; Sagie A.; Pitlik S.